Voyager Therapeutics, Inc. (VYGR)
NASDAQ: VYGR · Real-Time Price · USD
3.770
+0.010 (0.27%)
At close: Apr 28, 2026, 4:00 PM EDT
3.746
-0.024 (-0.63%)
After-hours: Apr 28, 2026, 7:12 PM EDT
Voyager Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Voyager Therapeutics stock have an average target of 16.5, with a low estimate of 8.00 and a high estimate of 25. The average target predicts an increase of 337.67% from the current stock price of 3.77.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 17, 2026.
Analyst Ratings
The average analyst rating for Voyager Therapeutics stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 2 | 1 |
| Buy | 3 | 3 | 3 | 3 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 3 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +563.13% | Mar 17, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $30 → $25 | Strong Buy | Maintains | $30 → $25 | +563.13% | Nov 12, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +695.76% | Sep 15, 2025 |
| Wedbush | Wedbush | Buy Maintains $9 → $8 | Buy | Maintains | $9 → $8 | +112.20% | Aug 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +695.76% | Apr 8, 2025 |
Financial Forecast
Revenue This Year
54.12M
from 40.37M
Increased by 34.04%
Revenue Next Year
58.40M
from 54.12M
Increased by 7.92%
EPS This Year
-1.85
from -2.04
EPS Next Year
-1.76
from -1.85
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 129.8M | 129.1M | ||||||
| Avg | 54.1M | 58.4M | ||||||
| Low | 7.8M | 7.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 221.4% | 138.5% | ||||||
| Avg | 34.0% | 7.9% | ||||||
| Low | -80.6% | -85.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -1.02 | -1.06 | ||||||
| Avg | -1.85 | -1.76 | ||||||
| Low | -2.51 | -2.54 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.